Compounded bioidentical hormones vs FDA-approved HRT

FDA-approved hormone therapy and compounded bioidentical hormones can contain the same hormones, but only the FDA-approved products have been tested in clinical trials and checked by the FDA for dose, purity and effectiveness. The major US medical groups recommend FDA-approved products first and compounded ones only when an approved product will not work for you.

"Bioidentical" does not mean compounded. Several FDA-approved products are bioidentical too. This guide explains the difference, what the FDA and the National Academies found, how the 2025 to 2026 boxed-warning changes apply, and which online programs dispense which.

What "bioidentical" actually means

A bioidentical hormone has the same chemical structure as the one your body makes. The Menopause Society's 2022 position statement notes that the term "can be misleading because there are both government-approved and compounded bioidentical hormone therapies" (The Menopause Society). FDA-approved bioidentical hormones include estradiol and micronized progesterone, sold as pills, patches, gels, sprays and vaginal products.

So the real choice is not "natural vs synthetic." It is FDA-approved vs compounded.

What compounded hormones are

A compounded hormone is mixed by a pharmacist from a prescription. The Menopause Society describes these products as able to "combine multiple hormones (estradiol, estrone, estriol, DHEA, testosterone, progesterone)" and to use "untested, unapproved combinations or formulations" or routes such as pellets and troches (The Menopause Society). Common online examples are estradiol creams, "bi-est" estradiol and estriol creams, and testosterone cream for women.

Who checks them depends on where they are made. The FDA explains that traditional compounding pharmacies (section 503A) are overseen mainly by state boards of pharmacy and are not held to manufacturing (CGMP) standards, while registered outsourcing facilities (503B) are FDA-inspected and must meet CGMP (FDA).

The FDA's position

The FDA is direct: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed" (FDA).

In 2018 the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to review the evidence on compounded bioidentical hormone therapy. NASEM delivered its analysis on 1 July 2020. Per the FDA's summary, it found a "lack of rigorous evidence of safety and effectiveness from well-designed or properly controlled clinical studies," that most information came from anecdotal claims and prescriber testimonies, and that widespread use "poses a public health concern" (FDA, NASEM study). When we checked in October 2026, we found no final FDA rule restricting compounding of these hormones.

What the medical societies recommend

The Menopause Society says compounded therapy "presents safety concerns, such as minimal government regulation and monitoring, overdosing and underdosing, presence of impurities and lack of sterility, lack of scientific efficacy and safety data, and lack of a label outlining risks." It adds that "Patient preference alone should not be used to justify" its use, and that compounding could be considered for allergies to an ingredient in an approved product or for a dose that approved products do not offer (The Menopause Society).

The American College of Obstetricians and Gynecologists (ACOG) reached the same view in its 2023 Clinical Consensus No. 6: compounded bioidentical therapy "should not be prescribed routinely when FDA-approved formulations exist," and patients who still want it should be told it lacks FDA approval (ACOG via PubMed). ACOG also advises against dosing by hormone level tests; a summary of the guidance says dosing "should be titrated to symptomatic relief and not serum level testing" (The ObG Project). The Menopause Society calls saliva and urine testing for dosing "unreliable and not recommended."

How strong is the evidence? The case against compounded hormones is mostly an absence of evidence: no large, long-term trials show they work as well or are as safe as approved products, and doses can vary batch to batch. That is not proof they harm most users. ACOG itself calls for high-quality randomized trials comparing the two. Until those exist, the approved products are the ones with known doses and known risks.

The 2025 to 2026 boxed-warning changes

On 10 November 2025, HHS and the FDA announced they were "initiating the removal of broad 'black box' warnings from HRT products for menopause," covering cardiovascular disease, breast cancer and probable dementia. The FDA said it is "not seeking to remove the boxed warning for endometrial cancer for systemic estrogen-alone products" (FDA). The same release repeats the labeled advice to start systemic HRT within 10 years of menopause onset or before age 60.

On 12 February 2026 the FDA approved the first labeling changes for six products across four categories, including vaginal estrogen, and said 29 companies had submitted proposed changes (FDA).

These changes apply to FDA-approved product labels only. Compounded hormones have no FDA label, so there was no boxed warning to remove.

Which online programs dispense which

Based on each program's own pages as recorded in our provider data on 26 October 2026:

If you want FDA-approved products only, ask the program to name the exact product and manufacturer before you pay.

What to ask a provider

• Is this exact product FDA-approved, or compounded? Ask for the brand or generic name.
• If compounded, why? A clear reason (an allergy, a dose not sold) is what the guidelines describe. "It's more natural" is not.
• Which pharmacy makes it, and is it a 503A pharmacy or a 503B outsourcing facility?
• If I have a uterus, what protects the lining? Women "with an intact uterus using systemic ET should receive adequate progestogen" (The Menopause Society). Ask how a compounded cream's progesterone dose was tested.
• Will you dose me by saliva or hormone tests? Both major societies advise against it.
• Can this go through my insurance? Generic FDA-approved products often can; compounded ones usually cannot. Our HRT cost guide has the detail.

FAQ

Are compounded bioidentical hormones the same as FDA-approved HRT?

No. They may contain the same hormones, but compounded products are not FDA-approved, are not tested in large trials, and can vary in dose. FDA-approved bioidentical estradiol and progesterone exist and are the first choice in current guidelines.

Compounded bioidentical hormones vs FDA-approved HRT: which is safer?

FDA-approved products have known doses, trial data and a label listing the risks. Compounded products lack all three. NASEM found a lack of rigorous evidence on safety and effectiveness of compounded hormones, which is a gap in evidence rather than proof of harm.

Did the boxed warning removal apply to compounded hormones?

No. The 2025 to 2026 changes update FDA-approved product labels. Compounded products have no FDA label.

When might compounded hormones make sense?

The Menopause Society names allergies to an ingredient in an approved product and doses that approved products do not offer. Testosterone for women is another case: ACOG notes there is no FDA-approved testosterone product for menopausal symptoms, so prescriptions are compounded or off-label.

Is "bioidentical" a sign of better quality?

No. It describes the molecule, not the manufacturing. Many FDA-approved products are bioidentical.

To compare what FDA-approved and compounded options cost at each program, see our price table or the best menopause programs.